| Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer H Chen, Y Pang, J Wu, L Zhao, B Hao, J Wu, J Wei, S Wu, L Zhao, Z Luo, ... European journal of nuclear medicine and molecular imaging 47, 1820-1832, 2020 | 415 | 2020 |
| Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers Y Pang, L Zhao, Z Luo, B Hao, H Wu, Q Lin, L Sun, H Chen Radiology 298 (2), 393-402, 2021 | 204 | 2021 |
| Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings H Chen, L Zhao, D Ruan, Y Pang, B Hao, Y Dai, X Wu, W Guo, C Fan, ... European journal of nuclear medicine and molecular imaging 48, 73-86, 2021 | 176 | 2021 |
| Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F … W Guo, Y Pang, L Yao, L Zhao, C Fan, J Ke, P Guo, B Hao, H Fu, C Xie, ... European journal of nuclear medicine and molecular imaging 48, 1604-1617, 2021 | 116 | 2021 |
| Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT L Zhao, Y Pang, Z Luo, K Fu, T Yang, L Zhao, L Sun, H Wu, Q Lin, H Chen European Journal of Nuclear Medicine and Molecular Imaging 48, 1944-1955, 2021 | 103 | 2021 |
| Integrin αvβ3-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy H Chen, L Zhao, K Fu, Q Lin, X Wen, O Jacobson, L Sun, H Wu, X Zhang, ... Theranostics 9 (25), 7948, 2019 | 83 | 2019 |
| Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review L Zhao, J Chen, Y Pang, K Fu, Q Shang, H Wu, L Sun, Q Lin, H Chen Theranostics 12 (4), 1557, 2022 | 79 | 2022 |
| Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of 68Ga-labeled FAPI dimer L Zhao, B Niu, J Fang, Y Pang, S Li, C Xie, L Sun, X Zhang, Z Guo, Q Lin, ... Journal of Nuclear Medicine 63 (6), 862-868, 2022 | 71 | 2022 |
| Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients … Y Pang, L Zhao, Q Shang, T Meng, L Zhao, L Feng, S Wang, P Guo, X Wu, ... European journal of nuclear medicine and molecular imaging, 1-16, 2022 | 59 | 2022 |
| Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and … L Zhao, Y Pang, H Zheng, C Han, J Gu, L Sun, H Wu, S Wu, Q Lin, ... European journal of nuclear medicine and molecular imaging 48, 3606-3617, 2021 | 54 | 2021 |
| 68Ga-FAPI PET/CT in assessment of liver nodules in a cirrhotic patient L Zhao, J Gu, K Fu, Q Lin, H Chen Clinical Nuclear Medicine 45 (10), e430-e432, 2020 | 48 | 2020 |
| 68Ga-FAPI outperforms 18F-FDG PET/CT in identifying bone metastasis and peritoneal carcinomatosis in a patient with metastatic breast cancer Y Pang, L Zhao, H Chen Clinical nuclear medicine 45 (11), 913-915, 2020 | 43 | 2020 |
| 68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer L Zhao, S Chen, S Chen, Y Pang, Y Dai, S Hu, L Fu, L Sun, H Wu, H Chen, ... Radiotherapy and Oncology 158, 55-61, 2021 | 40 | 2021 |
| PET imaging of fibroblast activation protein in various types of cancer using 68Ga-FAP-2286: comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study Y Pang, L Zhao, T Meng, W Xu, Q Lin, H Wu, J Zhang, X Chen, L Sun, ... Journal of Nuclear Medicine 64 (3), 386-394, 2023 | 34 | 2023 |
| [68Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer L Zhao, S Chen, L Lin, L Sun, H Wu, Q Lin, H Chen European journal of nuclear medicine and molecular imaging 47, 3188-3189, 2020 | 33 | 2020 |
| Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma L Zhao, Y Zhuang, K Fu, P Chen, Y Wang, J Zhuo, X Liao, H Chen, Q Lin European journal of nuclear medicine and molecular imaging 47, 1065-1074, 2020 | 27 | 2020 |
| Rational design and pharmacomodulation of protein-binding theranostic radioligands for targeting the fibroblast activation protein L Meng, J Fang, L Zhao, T Wang, P Yuan, Z Zhao, R Zhuang, Q Lin, ... Journal of Medicinal Chemistry 65 (12), 8245-8257, 2022 | 25 | 2022 |
| Differential diagnostic value of 18F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging X He, L Zhao, X Guo, L Zhao, J Wu, J Huang, L Sun, C Xie, H Chen Cancer management and research, 2105-2115, 2018 | 23 | 2018 |
| Development of fibroblast activation protein inhibitor-based dimeric radiotracers with improved tumor retention and antitumor efficacy L Zhao, J Chen, Y Pang, J Fang, K Fu, L Meng, X Zhang, Z Guo, H Wu, ... Molecular Pharmaceutics 19 (10), 3640-3651, 2022 | 22 | 2022 |
| Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD L Zhao, H Chen, Z Guo, K Fu, L Yao, L Fu, W Guo, X Wen, O Jacobson, ... Molecular cancer therapeutics 19 (10), 2034-2043, 2020 | 22 | 2020 |
Chen HaojunThe First Affiliated Hospital of Xiamen University在 stu.xmu.edu.cn 的电子邮件经过验证
